Migausky George V

Migausky George V is listed in filings as Director at REGENXBIO Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including 6 public disclosures. Recent filings connect the profile to REGENXBIO Inc. (RGNX) and Immunovant, Inc. (IMVT). The current snapshot covers public activity from Apr 3, 2025 to Jun 2, 2026. Reported amounts are shown as $326.7K to $115.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.